In our breast cancer patient cohort, we observed reduced HTRA1 expression levels particularly in patients exhibiting unfavorable clinical features such as high numbers of affected lymph nodes (≥4 lymph nodes; see Table 1). This evidence concerns the gene HTRA1 and breast cancer.